Perfil
Dayan Colin is currently the Chair of Clinical Diabetes and Metabolism and Head at the University of Cardiff, as well as a Partner and Advisor at JDRF T1D Fund.
Previously, he was the Director at the Institute of Molecular Immunology.
Mr. Colin received a doctorate degree from University College Oxford.
Cargos activos de Dayan Colin
| Empresas | Cargo | Inicio |
|---|---|---|
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Consultor / Asesor | - |
| University of Cardiff | Presidente | - |
Antiguos cargos conocidos de Dayan Colin.
| Empresas | Cargo | Fin |
|---|---|---|
| Institute of Molecular Immunology | Director/Miembro de la Junta | - |
Formación de Dayan Colin.
| University College Oxford | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
| Institute of Molecular Immunology | |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Finance |
- Bolsa de valores
- Insiders
- Dayan Colin
